Antimicrobials 2018
Industry Sessions
Tickets for the Breakfast Symposia are included in Antimicrobials 2018 full registration fees and will be available to register via the registration portal closer to the Meeting dates. You will be required to log back into your registration to indicate your attendance at these events. Further information regarding the symposia and ticket availability will be provided to all registered delegates by email approximately 2-3 weeks prior to the Meeting commencement.

Please note that the Breakfast Symposia are extremely popular each year and tend to reach capacity quickly, so we recommend you book early to avoid disappointment. 

Please note: The MSD, bioMérieux and BD breakfast symposia are now fully subscribed. 

MSD Symposia

MSD is pleased to invite you to their symposia on furthering understanding of contemporary infection and resistance issues at the 2018 ASA Annual Scientific Meeting at the Brisbane Convention and Exhibition Centre. 

Should you be unable to attend in person, the MSD Symposia will broadcast live, and may be accessed online for 24 hours. 


Thursday, 22nd February 2018
1:00 - 2:30 pm
Boulevard Auditorium

Chair: A/Prof Natalie Schellack

Antitoxin for the Prevention of Recurrent CDI - Professor Mark Wilcox

Management of Recurrent CDI - A/Prof Tony Korman

Clinical and Economic Consequences of Recurrent CDI - Prof Yehuda Carmeli

Friday, 23rd February 2018
1:00 - 2:30 pm
Boulevard Auditorium

Chair - David Paterson

Superbug Pseudomonas - Prof Iain Lamont

Challenges to Adequate Therapy for Pseudomonas aeruginosa - Why, When and Who to Treat

Practical Application of Risk Factors in Complex Patients in Malaysia - Dr Petrick Periyasamy

Saturday, 24th February 2018
7:00 - 8:45 am
Boulevard Room 3

AMS Breakfast Discussion - FULLY BOOKED

Chair: Dr Ankur Gupta

- Associate Professor Natalie Schellack - School of Pharmacy, Sefako Makgatho Health Sciences University, South Africa

Panel Discussion
Panellists - A/Prof Natalie Schellack, Prof Mark Wilcox, Dr Petrick Periyasamy, Prof Yehuda Carmeli, Dr David Andresen, Dr Minyon Avent, Dr David Grolman

A/Prof Natalie Schellack

Associate Professor Natalie Schellack is the acting Division Head of Clinical Pharmacy in the School of Pharmacy, Sefako Makgatho Health Sciences University. She holds three degrees, two bachelor degrees (nursing and pharmacy). She is part of the National Department of Health's paediatric essential medicine committee and the Tertiary/Quarternary Committee and serves on the Gauteng Provincial Pharmacy and Therapeutics Committee, and Sefako Makgatho Health Sciences Research and Ethics Committee. She is also the chairperson of the South African Society of Clinical Pharmacy. Natalie has supervised 50 master's degree students to completion. She has served as an external examiner to the Universities of Witwartersrand, Kwazulu-Natal, North-West and Nelson Mandela Metropolitan. She has written over 100 publications in the last six years and has successfully completed the course in Good Clinical Practice (GCP). In March 2017, Natalie was awarded the Newton Grant ENhancing Appropriate AntimicroBial use via mHeaLth and other techniques in the Republic of South Africa (ENAABLERS) Project.

bioMérieux Breakfast Symposium

Thursday, 22nd February 2018
7:00 - 08:45 am
Boulevard Rooms 1 & 2

How can the MIC guide antibiotic choices and doses in sepsis? - FULLY BOOKED

- Professor Jason Roberts

The talk will cover both theory and clinical cases on following issues:
- Data on the timelines of the effective antibiotic therapy in critically ill/septic patients
- What is an MIC and what are the various forms?
- What data exists relating different MICs to change in patient outcomes?
- How to include both considerations of pharmacokinetics and MIC in decisions to ensure better dosing for patients?

Professor Jason Roberts is a National Health and Medical Research Council Practitioner Fellow at The University of Queensland and Consultant Clinical Pharmacist at the Royal Brisbane and Women's Hospital. He is Director of Centre of Research Excellence REDUCE within the University of Queensland Centre for Clinical Research and is Director of the Centre for Translational Anti-infective Pharmacodynamics in the School of Pharmacy where he is also Chair of the Research Strategies Committee.

Professor Roberts has a strong interest in research and his principal research theme is optimisation of antibiotic dosing in the critically ill. He has been invited to present his results at major international conferences in critical care, infectious diseases, pharmacy, nephrology, transplantation and safety. He has published over 300 papers and book chapters and has > $25 million in grant funding for his research topics.

BD Breakfast Symposium

Friday, 23rd February 2018
7:00 - 8:45 am
Boulevard Rooms 1 & 2

The epidemiology of carbapenemase associated infections and the role of the laboratory in their detection - FULLY BOOKED

- Dr Tony Korman - Infectious Diseases Physician and Medical Microbiologist, Monash Medical Centre
- Mr Justin Ellem - Hospital Scientist, Westmead ICPMR

Mr Justin Ellem is a Hospital Scientist at the Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology, Westmead Hospital. He is the supervising scientist for infection control and rapid molecular diagnostics. Justin's core interests lay in the field of antimicrobial resistance, particularly that of gram-negative resistance; antimicrobial susceptibility testing; on-demand molecular testing and laboratory automation.

Dr Tony Korman is the Director of Infectious Diseases and Director of Microbiology at Monash Health, Victoria's largest health service, and Infection theme leader, Centre for Inflammatory Diseases and Associate Professor, Department of Medicine, School of Clinical Sciences, Monash University.

Cepheid Breakfast Symposium

Saturday, 24th February 2018
7:00 - 8:45 am
Boulevard Rooms 1 & 2

Next Generation Xpert MTB/RIF Ultra: Early Experience in a Low Burden Setting

Dr Sushil Pandey, Queensland Mycobacterium Reference Laboratory, Pathology Queensland

Dr Sushil Pandey is a Chief Scientist of Queensland Mycobacterium Reference Laboratory (QMRL), Pathology Queensland, with more than 10 years of mycobacterial experience. He holds a PhD (Medical Science) and MBA (Operations Management). Dr Pandey is a senior WHO consultant and a member of Regional Green Light Committee (Western Pacific Region) and provides mycobacterial related technical assistance/advice to countries such as Fiji, Nauru, Vanuatu, Papua New Guinea, Malaysia, Kenya and Sri Lanka. He holds an honorary Senior Lecturer position at the University of Queensland and is also involved in supervising research students. His research interest involves drug resistant TB.

Australian Commission on Safety and Quality in Healthcare Symposium

Saturday, 24th February 2018
1:00 - 2:00 pm
Boulevard Auditorium

2016 AURA Partner Programs:

2016 AGAR Amalgam Report 
Geoffrey Coombs

2016 NAPS and 2016 SNAPS 
Karin Thursky

2016 NAUSP Report Highlights and New Focus Areas
Vicki McNeil

2017 CARAlert
Jan Bell

Update on AURA
John Turnidge

There will be a five minute presentation on each programme followed by twenty minutes of questions and discussion. All delegates are invited to attend and lunch will be provided.